Home
News
Videos
Podcasts
Slides
Visual Abstracts
Topics
Conferences
- SCAI 2018
- ACC 2018
- AHA 2017
- ESC 2017
- SCAI 2017
- ACC 2017

Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis – The PRECISION Trial

By Usama Nasir, M.D. on April 1, 2018

Source: NEJM

t f

IVUS-Guided DES Reduced MACE at 1 year Compared to Angiography-Guided PCI: IVUS-ACS Trial

Key Points: The IVUS-ACS trial assessed whether the use of intravascular ultrasound guidance, as compared… Continue Reading

By Alberto Castro Molina
April 10, 2024

IVUS -DBC: IVUS-guided drug-coated balloon angioplasty improves primary patency

Key Points: One-year success rates of angioplasty in peripheral artery disease (PAD) patients were significantly… Continue Reading

By Alberto Castro Molina
April 10, 2024

A technology assisted Web App allowed >90% of consumers to correctly self-select for statin use and achieve clinically important LDL-C reduction

Key Points: Nonprescription statin access may help statin-eligible patients receive appropriate treatment. This prospective, actual-use… Continue Reading

By Lucas Marinacci
April 10, 2024

Create an Account

CLICK TO REGISTER

Cardiology Now News is sponsored by the Baim Institute for Clinical Research and produced by the PERFUSE Study Group. Baim and PERFUSE are academic research organizations led by world class cardiovascular clinical trialists and opinion leaders.

Receive the latest news, interviews, podcasts directly to your inbox

Leave a Reply Cancel reply

More from

IVUS-Guided DES Reduced MACE at 1 year Compared to Angiography-Guided PCI: IVUS-ACS Trial

IVUS -DBC: IVUS-guided drug-coated balloon angioplasty improves primary patency

A technology assisted Web App allowed >90% of consumers to correctly self-select for statin use and achieve clinically important LDL-C reduction